Skip to main content

Advertisement

Table 1 Demographic characteristics–overall and by treatmenta

From: The impact of free trial acceptance on demand for alternative nicotine products: evidence from experimental auctions

  Overall (N = 258) Control (N = 62) Snus trial (N = 64) Nicorette trial (N = 67) Ariva trial (N = 65) Offered and tried the ST product (N = 115) Offered but did not try the ST product (N = 81)
Race–white 65 % 66 % 67 % 66 % 60 % 68 % 59 %
Race–black 28 % 31 % 23 % 27 % 32 % 27 % 28 %
Race–other 7 % 3 % 9 % 7 % 8 % 5 % 12 %
Age–under 30 yearsb 38 % 27 % 36 % 39 % 51 % 44 % 38 %
Age–30 to 50 years 38 % 35 % 41 % 36 % 38 % 39 % 37 %
Age–over 50 yearsb 24 % 37 % 23 % 25 % 11 % 17 % 25 %
Female 44 % 39 % 41 % 51 % 45 % 38 %c 55 %
Income–below 30 K 57 % 56 % 63 % 49 % 58 % 54 % 60 %
Income–between 30 and 60 K 10 % 19 % 09 % 10 % 11 % 14 % 14 %
Income–over 60 K 15 % 10 % 11 % 13 % 17 % 10 % 10 %
Income–chose not to reveal 18 % 15 % 17 % 27 % 14 % 22 % 16 %
Moderately or very worried about future quality of life 61 % 61 % 59 % 64 % 58 % 62 % 59 %
Prior smokeless tobacco use 43 % 39 % 50 % 43 % 38 % 55 %c 28 %
Observations–NY 36 % 39 % 33 % 36 % 38 % 38 % 30 %
Observations–SC 34 % 35 % 36 % 37 % 29 % 32 % 37 %
Observations–PA 29 % 26 % 31 % 27 % 32 % 30 % 31 %
  1. aAuctions conducted from November 2010–November 2011
  2. bThe only demographic characteristics that differed across treatment groups at a significance level of 0.05 or less was the over 50 age group (p < 0.01). No other differences in demographic characteristics were found to be significant at the 5 % level using a chi-squared test
  3. cThe only demographic or background characteristics where there were statistically significant differences in the percentage who tried ST products was for females (p < 0.05) and for those who had used smokeless tobacco at some point in the past (p < 0.01)